| SCHEDULE OF BUSINESS SEGMENT |
SCHEDULE OF BUSINESS SEGMENT
| | |
March
31, 2026 | | |
December
31, 2025 | |
| | |
| | |
| |
| Healthcare | |
$ | 41,824,419 | | |
$ | 40,869,803 | |
| Life Science Services | |
| 3,830,873 | | |
| 3,648,500 | |
| Labs | |
| 19,034 | | |
| 15,854 | |
| Corporate
and other | |
| 111,808 | | |
| 43,716 | |
| Total
assets | |
$ | 45,786,134 | | |
$ | 44,577,873 | |
Summarized
below is information about the Company’s operations for the three months ended March 31, 2026 and 2025 by business segment:
| | |
Net
Revenues | | |
Earnings
(Losses) | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Healthcare | |
$ | 4,798,551 | | |
$ | 3,161,431 | | |
$ | 296,914 | | |
$ | (844,598 | ) |
| Life Science Services | |
| 361,250 | | |
| - | | |
| 142,416 | | |
| - | |
| Labs | |
| 4,386 | | |
| 8,489 | | |
| (32,370 | ) | |
| (23,005 | ) |
| | |
| 5,164,187 | | |
| 3,161,431 | | |
| 406,960 | | |
| (867,603 | ) |
| Loss on legal settlement | |
| - | | |
| - | | |
| (18,250 | ) | |
| - | |
| Gain from extinguishment
of Senior PIK Notes | |
| - | | |
| - | | |
| - | | |
| 1,863,834 | |
| Corporate and other | |
| 3,849 | | |
| - | | |
| (867,680 | ) | |
| (722,897 | ) |
| Interest
expense | |
| - | | |
| - | | |
| (973,003 | ) | |
| (889,792 | ) |
| Total | |
$ | 5,168,036 | | |
$ | 3,169,920 | | |
$ | (1,451,973 | ) | |
$ | (616,458 | ) |
|